Medicx Fund Regulatory News (MXF)

For immediate release 2 September 2010

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Total Voting Rights

In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 31 August 2010 was 140,394,740 with each share holding one voting right. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

End

For further information please contact:

MedicX Group +44 (0)1483 869 500

Keith Maddin, Chairman

Mike Adams, Managing Director

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited +44 (0)20 7523 8000

Andrew Zychowski/Lucy Lewis

Buchanan Communications +44(0)20 7466 5000

Charles Ryland/George Prassas

MedicX Fund Limited +44 (0)1481 723 450

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK.

 The Company's website address is www.medicxfund.com.